In rats with COPD, bronchogen treatment reduced neutrophilic inflammation.
In plain wordsIn rats with COPD, bronchogen reduced neutrophilic inflammation.
- Peptide
- Bronchogen (AEDL)
- Outcome
- DecreaseNeutrophilic inflammation
- Study
ratn: not reported in source
Nitrogen dioxide-induced COPD- Outcome group
- Inflammation markers · Respiratory
- Studied dose
- Dose not stated
Source sentences
Following the course of peptide treatment the decreased activity of neutrophilic inflammation with the normalization of cellular composition and profile of pro-inflammatory cytokines and enzymes in the bronchoalveolar space was observed.
1 context sentence(design, population, supporting numbers)
The effect of the tetrapeptide bronchogen on the structural and functional state of the bronchial epithelium and inflammatory activity in the lungs was studied in the chronic obstructive pulmonary disease (COPD) model, created in rats by a 60-day intermittent exposure to nitrogen dioxide.